JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Inicio・Lista de Acciones・CorMedix Inc

CorMedix Inc

Cerrado

SectorSanidad

7.78 2.77

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

7.57

Máximo

7.84

Métricas clave
By Trading Economics
Ingresos	-95M 14M
Ventas	24M 129M
P/B Media del Sector	3.833 67.147
BPA	0.16
Margen de beneficios	10.901
Empleados	191
EBITDA	9.2M 66M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+76.51% upside

Dividendos
By Dow Jones
Próximas Ganancias	5 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	50M 618M
Apertura anterior	5.01
Cierre anterior	7.78

Noticias sobre sentimiento de mercado

By Acuity

51%

49%

289 / 347 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

9.2 / N/A Soporte y Resistencia

CorMedix Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

1 may 2026, 21:36 UTC

Adquisiciones, fusiones, absorciones

FTC Requires 365 Retail Markets to Divest Micromarket Kiosk Business to Clear Acquisition of Cantaloupe

1 may 2026, 20:40 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms Acquires Humanoid Robot Startup Assured Robot Intelligence

1 may 2026, 18:37 UTC

Principales Movimientos del Mercado

Senseonic Shares Slide on Underwritten Offering Price

1 may 2026, 16:46 UTC

Principales Movimientos del Mercado

Stellantis, Ferrari Fall on Trump Plan to Increase Tariff on European Cars, Trucks

1 may 2026, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

1 may 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

1 may 2026, 20:42 UTC

Ganancias

Western Digital Beats Earnings Estimates. The Stock Is Falling Anyway. -- Barrons.com

1 may 2026, 19:33 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

1 may 2026, 19:33 UTC

Charlas de Mercado

Change in Fed Leadership May Hamper Crypto Rebound -- Market Talk

1 may 2026, 19:18 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Rises for Second Consecutive Week Amid Middle East Standoff -- Market Talk

1 may 2026, 19:13 UTC

Charlas de Mercado

Natural Gas Rises as Markets Wait for Warmer Temperatures -- Market Talk

1 may 2026, 18:36 UTC

Ganancias

3 Takeaways From Apple Earnings. The Stock Is Surging. -- Barrons.com

1 may 2026, 18:35 UTC

Ganancias

Moderna's Covid Vaccine Is Driving Growth Again. The Stock Is Down Anyway. -- Barrons.com

1 may 2026, 18:28 UTC

Ganancias

These Stocks Are Today's Movers: Apple, Sandisk, Roblox, Intel, Ferrari, Atlassian, Western Digital, Clorox, Paramount Skydance, and More -- Barrons.com

1 may 2026, 18:27 UTC

Charlas de Mercado

Gold and Silver Higher for the Day, Lower For The Week -- Market Talk

1 may 2026, 18:14 UTC

Adquisiciones, fusiones, absorciones

Barclays Completes Acquisition of Best Egg

1 may 2026, 18:04 UTC

Ganancias

The First $6 Trillion Company May Not Be Nvidia -- Barrons.com

1 may 2026, 17:43 UTC

Charlas de Mercado

Home Sales in San Francisco Jump 22.2% in March -- Market Talk

1 may 2026, 17:37 UTC

Charlas de Mercado

Crypto 'Fear and Greed Index' Returns to Neutral Reading After Brief Dip -- Market Talk

1 may 2026, 17:30 UTC

Charlas de Mercado

Ganancias

Apple's 2Q Print, 3Q Guide Set Up Stock to Outperform -- Market Talk

1 may 2026, 17:28 UTC

Charlas de Mercado

Ganancias

Apple's Shift From Net Cash Neutral Goal Seen as Cryptic Signal -- Market Talk

1 may 2026, 17:21 UTC

Charlas de Mercado

Ganancias

Apple Seen Absorbing Higher Memory Costs -- Market Talk

1 may 2026, 17:19 UTC

Charlas de Mercado

Noticias de Eventos Importantes

U.S. Oil Rig Count Rises by 1 to 408 -- Market Talk

1 may 2026, 16:38 UTC

Charlas de Mercado

Institutional Markets Begin to Trade on Event Contracts -- Market Talk

1 may 2026, 16:23 UTC

Adquisiciones, fusiones, absorciones

Paramount Skydance Gets a Double Upgrade. It's the Warner Bros. Deal. -- Barrons.com

1 may 2026, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

1 may 2026, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

1 may 2026, 16:15 UTC

Ganancias

This AI Stock Is Up 78% This Year. Why It Still Looks Like a Buy. -- Barrons.com

1 may 2026, 16:11 UTC

Charlas de Mercado

Bank of Canada Committed a 'Messaging Blunder' -- Market Talk

1 may 2026, 16:04 UTC

Ganancias

Exxon Stock Slips. CEO Warns 'Full Impact' of War is Coming. -- Barrons.com

Comparación entre iguales

Cambio de precio

CorMedix Inc previsión

Precio Objetivo

By TipRanks

76.51% repunte

Estimación a 12 Meses

Media 13.75 USD 76.51%

Máximo 15 USD

Mínimo 13 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CorMedix Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para CorMedix Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

9.2 / N/ASoporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bullish.

Sentimiento

By Acuity

289 / 347 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.